Dracaena cinnabri is a popular medicinal plant in the peninsula of Arabia and other countries, used as an herbal cure for a variety of ailments such as astringent, analgesic, antibacterial, and antiulcer. The present research investigation sought to identify the phytochemical components and assess the hemostatic impact of Dracaena cinnabri extracts in aqueous, ethanol, and chloroform forms. Soxhlet extraction has been employed to isolate and identify secondary metabolites in plants. Several widely used and accessible standard assays were performed for phytochemical screening. Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT) are two examples of biochemical assays that are frequently used to examine hemostatic potential. Tukey's HSD and one-way ANOVA were used to evaluate the information. The presence of active substances, including phenolic compounds, flavonoids, tannins, and saponins, in high concentrations was revealed by phytochemical screening. The aqueous extract caused a big drop in both PT and APTT levels, which means it had a high pro-coagulant effect and potentially had a haemostatic effect. The ethanol extract, on the other hand, did not have any haemostatic activity, and the chloroform extract had a mild effect. The remarkable action of the aqueous extract may be ascribed to its elevated concentration of saponins, tannins, and phenolic substances. These results indicate that aqueous extract of Dracaena cinnabari resin exhibits significant in vitro haemostatic properties; still, additional research is required to clarify the precise mechanism of action and validate its clinical significance.
This work is licensed under a Creative Commons Attribution 4.0 International License.
